Leaderboard Ad

2021 Inhibitor Virtual Education Series - Part 4

-

 

When you live with hemophilia with an inhibitor, you and your family have questions and concerns that deserve special attention. NHF’s 2021 Virtual Inhibitor Education Series will provide just that – quality education and meaningful community support in an all-virtual environment to protect your health.

If you are a person with hemophilia A or B with an active or tolerized inhibitor or support a person with one, or if you would like to learn more about this topic, we invite you to register for the fourth part of the series addressing the topic of joint health and pain management held on Saturday, November 6, 2021, starting at 3:00PM EST/2:00PM CST/1:00PM MST/12:00PM PST/10:00AM HST. The event is free and open to everyone from around the world.

Registration for the event will provide a personal link via email to access the event, and all sessions will be held in the same virtual room. Please note registration for the event will close an hour before the event start time.

 

Learn More & Register Here

 

Event Agenda


Session I: 3:00PM ET to 3:50PM ET
An opening panel of community members sharing their lived experience on the topic of joint health and pain management.

Industry Roundtable - 4:00PM ET to 4:30PM ET
Chat with our industry sponsors and learn about new products and programs.

Industry Roundtable - 4:00PM ET to 4:30PM ET
Chat with our industry sponsors and learn about new products and programs.

Wellness Break - 4:35PM ET to 4:45PM ET
Join Jhon Velasco for a wellness break centered on mindfulness and gentle movement.

Session II - 4:45PM ET to 5:30PM ET
A scientific, evidence-based information session on the topic of joint health and pain management.

Industry Roundtable - 5:40PM ET to 6:15PM ET
Chat with our industry sponsors and learn about new products and programs.

Sponsor Roundtable 5:40PM ET to 6:15PM ET
Chat with our sponsor and learn about programs.

Session III - 6:25PM ET to 7:10PM ET
A session featuring peer to peer engagement on the topic of joint health and pain management.

 

For more information, please email Inhibitors@hemophilia.org

 

Genentech HEMA Biologics
Sanofi Genzyme Takeda